• $83.5M
    Market Cap
  • -32.96%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 44
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$9.38
$9.71
$9.50
1-Year Range
$7.09
$16.50
$9.50
Latest Close$9.50
Change
-$0.17 (-1.79%)
Volume8,060
Market Cap$83.5M
Shares Outstanding8.5M
P/E (TTM)-36.18
Diluted EPS (TTM)-$0.27
Enterprise Value$82.0M

Information as of 06/02/2026

Company Profile

$83.5M
Market Cap
-$2.3M
Net Income
Sector: Healthcare
Industry: Biotechnology
750 Royal Oaks Drive, Monrovia, CA, United States, 91016
626 415 1488

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Key Executives

  • Michael Heltzen
  • Damien A. Perriman
  • Tyler Korman
  • Fouad Nawaz
  • Paul Opgenorth

Current Ownership Distribution

  • Other6.9M (80.80%)
  • Insiders1.5M (18.11%)
  • Institutions62,895 (0.74%)
  • Mutual Funds29,029 (0.34%)